Indication

Hypochondroplasia

1 clinical trial

1 product

1 drug

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vosoritide in Children With Hypochondroplasia

Status: , Estimated PCD: 2026-08-01

Product

Drug